After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has ...

AI has been hailed as a way to speed up historically sluggish drug development, but an entirely AI-designed drug has yet to be approved by the FDA. The furthest along is likely Insilico Medicine’s ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s no mystery as to why many wish to be underweight in ...

Protai, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI ...

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop ...

LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Location: Hilton London Kensington 179-199 Holland Park Avenue London W11 4UL United Kingdom ...

Under the agreement, Insilico Medicine will receive R&D funding for each programme.

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...